About US
Contact us
-
SFDA issues the Second Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 2010On July 1, 2010, the State Food and Drug Administration (SFDA) issued the Second Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 2010.2010/7/12
-
Merck to lay off 15 percent of workers, close plants, research facilitiesThe New York Times: Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operationsduring the next two years be2010/7/12
-
HHS to give states $25 million for HIV drugs; Researchers identify antibodies that may help in AIDS vaccine researchGA_googleFillSlot("NewsMedicalSquares"); The New York Times: Health and Human Services Secretary Kathleen Sebelius said Thursday"that she would provide2010/7/12
-
SFDA issues announcement on relevant issues concerning the implementation of 2010 Chinese PharmacopoeiaThe 2010 edition of Chinese Pharmacopoeia has been promulgated by the Ministry of Health ([2010] No.5 Announcement) and will be enforced from October 1, 2010. The State Food and Drug Administration2010/7/9
-
SFDA defines application requirements for fragrance materials in cosmetic formulationsIn order to enhance the management of the application of fragrance materials in cosmetic formulations, The State Food and Drug Administration (SFDA) recently issued a notice on relevant issues conce2010/7/9
-
ASPREE study aims to assess health benefits of aspirinIn an effort to extend the length of a disability-free life for older adults, researchers from Rush University Medical Center are partnering with colleagues from across the U.S. and Australia in the2010/7/8
-
Winston submits NDA for CIVANEX to U.S. FDAWinston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. ("Winston") (OTC PINK: WPHM), a pharmaceutical company focused on developing and commercializing novel pain man2010/7/8
-
Three Rivers Pharmaceuticals receives FDA expanded labeling for INFERGENThree Rivers Pharmaceuticals, LLC, today received expanded labeling from the U.S. Food and Drug Administration (FDA) to include daily use of INFERGEN (Consensus Interferon) in combination with ribav2010/7/7
-
Bacterin International Obtains ISO CertificationBELGRADE, MONTANA, MARCH 29, 2010 --- Bacterin International, Inc. (Bacterin), a medical device and biologics manufacturing company, is pleased to announce it has received certification from the Inter2010/7/7
-
Bayer's CONTOUR USB Blood Glucose Meter Wins Medical Design Excellence AwardTARRYTOWN, NY, JUNE 9, 2010 --- Bayer's CONTOUR(R) USB meter, the first blood glucose monitor with unique plug & play diabetes management software, today received a silver Medical Design Excelle2010/7/7